Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/1041-a-phase-1phase-2-study-to-evaluate-the-safety-and-tolerability-of-mk-1088-as-monotherapy-and-in-combination-with-pembrolizumab-in-participants-with-advanced-solid-tumors/publications